Safeguard plan approved by judgment of the Paris Commercial Court on November 12, 2025
Launch of a reserved capital increase in the form of shares with attached warrants (ABSA) at a price of €0.0973
Opening of an offer to retail investors via the PrimaryBid platform
Trading of shares will be suspended for the day of November 13, 2025, to ensure the smooth running of the operations
Paris and Boston, November 13, 2025 – 7:45 a.m. CET – Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that, by a judgment rendered on November 12, 2025, the Paris Commercial Court (the “Court”) has approved its safeguard plan (the “Plan”) presented during the hearing of October 27, 2025.
This decision ratifies the approval of the Plan by the affected parties (creditors and shareholders) last October and puts an end to the safeguard proceedings initiated on March 31, 2025.
The exit from the safeguard proceedings allows the Company to immediately launch the planned reserved capital increase, for a minimum amount of €5m, and the main terms of which were presented in the press releases of October 8 and 21, 2025, and are detailed in the Appendix.
Mr. Sacha Loiseau, Chief Executive Officer, has committed to participate in the capital increase for an amount of €100,000.
The terms of the capital increase will be as follows:
Subscription price of the ABSA (shares with attached warrants): €0.0973 per ABSA (corresponding to the volume-weighted average price (VWAP) of the last 10 trading days); and
Share Subscription Warrants (BSA): one BSA attached to each ABSA. Each BSA will entitle the holder to subscribe for one (1) new share for 5 years at an exercise price of €0.1216 per share, corresponding to 125% of the subscription price.
To involve all its shareholders and retail investors in this new stage, the Company announces that a dedicated offer will be accessible to them in France via the PrimaryBid platform. This offer will run in parallel with the bookbuilding process, which begins today, and under the same financial conditions. The PrimaryBid offering is secondary to the reserved capital increase provided for in the Plan and will be capped at a maximum amount corresponding to 20% of the amount of the reserved capital increase.
Sacha Loiseau, Chairman, CEO, and founder of Mauna Kea Technologies, commented: “A decisive step was taken today with the Court’s approval of the safeguard plan, marking our official exit from the proceedings we voluntarily initiated on March 31. We can now launch the reserved capital increase provided for in the safeguard plan, in which I have committed to participate and for which the minimum amount is already secured. It was essential for us to involve all our shareholders in this new beginning. That is why, in addition to the future allocation of free warrants (BSA), we are pleased to open this operation to individual investors via PrimaryBid. Mauna Kea Technologies is entering a new phase, supported by a strengthened financial structure and renewed investor confidence, paving the way for a sustainable cycle of value creation for all stakeholders.”
